Characterization and Evaluation of a Folic Acid Receptor-Targeted Norcantharidin/Tetrandrine Dual-Drug Loaded Delivery System

Figure 14

The effect of different concentrations of FA-LP@Tet/(MSNs@NCTD) on HepG2 and HepG2/Adr cell apoptosis, respectively. HepG2 and HepG2/Adr cells were treated with FA-LP@Tet/(MSNs@NCTD) at the concentrations from 0 μg/mL to 16 μg/mL for 24 h and then stained with DAPI.